Lumida
/DCGO
⌘K
DocGo Inc

DocGo Inc

DCGO
$0.35USD-3.53%-0.01 today

MARKET CAP

34.9M

P/E (TTM)

FWD P/E

DAY RANGE

$0 – $0

52W RANGE

$0
$2

AI Summary

Stalk
TrimMedium

DCGO remains entrenched in a Stage 4 decline with a persistent sequence of lower highs and lower lows under declining EMAs. The medium-term bias is Bearish, reinforced by pattern continuation and lack of stabilization, while short-term bounce attempts have failed to reclaim EMAs. Execution timing is unfavorable for selling now, so we Trim exposure on rallies into the 9EMA–20EMA zone and await further confirmation of downtrend continuation.

  • Upgraded 2026 revenue guidance to $300–315M.
  • Non-migrant mobile health revenues jumped 78% YoY.
  • Q2 revenue declined 8.8% YoY to $73.4M.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$318.7M$440.5M$624.3M$616.6M$322.2M
YoY %+38.2%+41.7%-1.2%-47.7%
P / Sales2.8x1.7x0.9x0.8x0.3x
EV / Sales2.5x1.6x1.1x0.8x0.4x
Gross Profit, Adj.$109.7M$154.7M$195.4M$213.6M$98.8M
YoY %+41.0%+26.3%+9.3%-53.8%
Margin %34.4%35.1%31.3%34.6%30.7%
EV / Gross Profit7.2x4.6x3.4x2.4x1.3x
EBITDA, Adj.$22.4M$32.4M$38.2M$57.1M$-54.9M
YoY %+44.4%+18.0%+49.4%-196.1%
Margin %7.0%7.4%6.1%9.3%-17.0%
EV / EBITDA35.4x22.2x17.6x9.0x-2.3x
EBIT$15.4M$21.8M$15.1M$28.7M$-178.0M
YoY %+42.2%-31.0%+90.6%-720.6%
Margin %4.8%5.0%2.4%4.7%-55.3%
EV / EBIT51.7x32.9x44.6x18.0x-0.7x
Net Income$23.7M$34.6M$6.9M$20.0M$-182.4M
YoY %+45.7%-80.2%+191.5%-1012.4%
Net Margin7.4%7.9%1.1%3.2%-56.6%
EPS (GAAP)$0.25$0.34$0.06$0.18-$1.84
YoY %+36.0%-82.4%+200.0%-1122.2%